219 related articles for article (PubMed ID: 17318795)
1. The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
Negro R; Hassan H
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):243-6. PubMed ID: 17318795
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
Yamagishi S; Takeuchi M
Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
[TBL] [Abstract][Full Text] [Related]
4. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Sawada K
Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
[TBL] [Abstract][Full Text] [Related]
5. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
Fogari R; Derosa G; Zoppi A; Preti P; Lazzari P; Destro M; Fogari E; Rinaldi A; Mugellini A
Am J Hypertens; 2007 Apr; 20(4):417-22. PubMed ID: 17386350
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
Usui I; Fujisaka S; Yamazaki K; Takano A; Murakami S; Yamazaki Y; Urakaze M; Hachiya H; Takata M; Senda S; Iwata M; Satoh A; Sasaoka T; Ak ND; Temaru R; Kobayashi M
Diabetes Res Clin Pract; 2007 Aug; 77(2):210-4. PubMed ID: 17240472
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
Mori H; Okada Y; Arao T; Nishida K; Tanaka Y
Adv Ther; 2012 Jul; 29(7):635-44. PubMed ID: 22821644
[TBL] [Abstract][Full Text] [Related]
8. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.
Shimabukuro M; Tanaka H; Shimabukuro T
J Hypertens; 2007 Apr; 25(4):841-8. PubMed ID: 17351377
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
[TBL] [Abstract][Full Text] [Related]
10. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Nakamura T; Inoue T; Suzuki T; Kawagoe Y; Ueda Y; Koide H; Node K
Hypertens Res; 2008 May; 31(5):841-50. PubMed ID: 18712038
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
Vecchiet J; Ucciferri C; Falasca K; Mancino P; Di Iorio A; De Caterina R
Antivir Ther; 2011; 16(5):639-45. PubMed ID: 21817185
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
Marketou ME; Kontaraki JE; Tsakountakis NA; Zacharis EA; Kochiadakis GE; Arfanakis DA; Parthenakis F; Chlouverakis G; Vardas PE
Am J Cardiol; 2011 Jan; 107(1):59-63. PubMed ID: 21146687
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
[TBL] [Abstract][Full Text] [Related]
14. Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
Sharma AM; Bakris G; Neutel JM; Littlejohn TW; Kobe M; Ting N; Ley L
Clin Ther; 2012 Mar; 34(3):537-51. PubMed ID: 22386829
[TBL] [Abstract][Full Text] [Related]
15. Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients.
Watanabe M; Inukai K; Sumita T; Ikebukuro K; Ito D; Kurihara S; Ono H; Awata T; Katayama S
Intern Med; 2010; 49(17):1843-7. PubMed ID: 20823643
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan in the treatment of Cohen-Rosenthal Diabetic Hypertensive rats: the benefit of PPAR-gamma agonism.
Younis F; Kariv N; Nachman R; Zangen S; Rosenthal T
Clin Exp Hypertens; 2007 Aug; 29(6):419-26. PubMed ID: 17729058
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension.
Nakayama S; Watada H; Mita T; Ikeda F; Shimizu T; Uchino H; Fujitani Y; Hirose T; Kawamori R
Hypertens Res; 2008 Jan; 31(1):7-13. PubMed ID: 18360012
[TBL] [Abstract][Full Text] [Related]
18. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
[TBL] [Abstract][Full Text] [Related]
19. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Ando K; Isshiki M; Takahashi K;
Hypertens Res; 2009 Sep; 32(9):748-52. PubMed ID: 19590506
[TBL] [Abstract][Full Text] [Related]
20. Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu).
Nakamoto H; Nishida E; Ryuzaki M; Sone M; Suzuki H; Yoshimoto M; Itagaki K
Clin Exp Hypertens; 2008 Jan; 30(1):57-67. PubMed ID: 18214734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]